| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/28/2007 | EP1766017A1 Tumor specific antibody |
| 03/28/2007 | EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 03/28/2007 | EP1766013A2 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 03/28/2007 | EP1766011A1 Polypeptide ligands containing linkers |
| 03/28/2007 | EP1766006A2 Mucin3 egf-like domains |
| 03/28/2007 | EP1765990A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 03/28/2007 | EP1765873A1 Methods and compositions using cd3 agonists |
| 03/28/2007 | EP1765863A1 Peptide-based compounds |
| 03/28/2007 | EP1765862A2 Heparin binding peptide |
| 03/28/2007 | EP1765861A2 Fgfr binding peptides |
| 03/28/2007 | EP1765860A2 High affinity ny-eso t cell receptor |
| 03/28/2007 | EP1765858A2 Epitope analogs |
| 03/28/2007 | EP1765853A2 O-linked glycosylation of peptides |
| 03/28/2007 | EP1765852A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member |
| 03/28/2007 | EP1765851A2 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |
| 03/28/2007 | EP1765850A1 Substituted propane phosphinic acid derivatives |
| 03/28/2007 | EP1765392A2 Apoptosis-inducing polypeptides |
| 03/28/2007 | EP1765390A2 Method for preventing and treating alzheimer´s disease |
| 03/28/2007 | EP1765388A2 Combination therapy for preventing or treating alzheimer's disease, and kit therefor |
| 03/28/2007 | EP1765384A1 Method of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
| 03/28/2007 | EP1765383A1 Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections |
| 03/28/2007 | EP1765382A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides |
| 03/28/2007 | EP1765381A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/28/2007 | EP1765380A1 Method of treating parkinson"s disease in humans by direct infusion of glial cell-line derived neurotrophic factor into the zona incerta |
| 03/28/2007 | EP1765378A2 Agent capable of downregulating an msf-a-dependent hif-1a anduse thereof in cancer treatment |
| 03/28/2007 | EP1765377A2 Medicament |
| 03/28/2007 | EP1765376A1 Topical compositions and methods for epithelial-related conditions |
| 03/28/2007 | EP1765375A1 Method for inhibiting angiogenesis and/or lymphangiogenesis |
| 03/28/2007 | EP1765374A2 Compositions, methods and uses for a novel family of peptides |
| 03/28/2007 | EP1765367A1 Phospholipid compositions and methods for their preparation and use |
| 03/28/2007 | EP1765365A2 Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
| 03/28/2007 | EP1765362A2 Compositions and methods for treatment of neovascular diseases |
| 03/28/2007 | EP1765299A1 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 03/28/2007 | EP1765294A1 Nucleic acid microspheres, production and delivery thereof |
| 03/28/2007 | EP1765219A1 Medical devices composed of porous metallic materials for delivering biolgically active materials |
| 03/28/2007 | EP1765083A2 Use of il-17 in the treatment of fertility-related disorders |
| 03/28/2007 | EP1765065A2 Methods and compositions related to delivery of chemical compounds to invertebrate embryos |
| 03/28/2007 | EP1581254A4 Pharmacological vitreolysis |
| 03/28/2007 | EP1556492A4 Antifreeze proteins isolated from forage grasses and methods for their use |
| 03/28/2007 | EP1554305B1 Prion protein-binding peptide sequences |
| 03/28/2007 | EP1474441B1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c) |
| 03/28/2007 | EP1403371B1 Polypeptide having a cell death inhibitory activity |
| 03/28/2007 | EP1335733B1 Treatment of osteoporosis |
| 03/28/2007 | EP1307212B1 Plant derived antioxidants |
| 03/28/2007 | EP1254944B1 Dry compositions containing hydrophobic amino acid |
| 03/28/2007 | EP1169349B1 Process for preparing gonadotropin compositions |
| 03/28/2007 | EP1082416B1 Poly(adp-ribose)polymerase gene |
| 03/28/2007 | EP1059089B1 Preventives/remedies for inflammatory intestinal disease |
| 03/28/2007 | EP0991426B2 Method for transferring nucleic acid into the striated muscle |
| 03/28/2007 | EP0773789B1 Use of MHC xenoantigen in the manufacture of a medicament for the treatment of cancer |
| 03/28/2007 | CN1938334A Combined use of a GLP-1 agonist and gastrin compounds |
| 03/28/2007 | CN1938333A Interleukin-11 fusion proteins |
| 03/28/2007 | CN1938332A Inhibitors of serine proteases, particularly HCV NS3-HS4A protease |
| 03/28/2007 | CN1938046A Monomethylvaline compounds capable of conjugation to ligands |
| 03/28/2007 | CN1938045A Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 03/28/2007 | CN1938043A Y2/Y4 selective receptor agonists for therapeutic interventions |
| 03/28/2007 | CN1938042A Methods for reducing oxidative damage |
| 03/28/2007 | CN1938041A Influenza virus-infection inhibitor |
| 03/28/2007 | CN1938040A Oxytocin controlled release formulations and methods of using same |
| 03/28/2007 | CN1938008A Sustained-release preparations |
| 03/28/2007 | CN1937914A 离子通道 Ion channels |
| 03/28/2007 | CN1936023A Diagnostic and monitoring methods for bone loss |
| 03/28/2007 | CN1936001A Goose B lymphocyte stimulating factor CDNA, and its cloning method and recombinant use |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1935838A Thymosin beta4 derivative and itsuse |
| 03/28/2007 | CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935259A Ultrasonic microvesicle as immuno adjuvant and vaccine carrier |
| 03/28/2007 | CN1935257A Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method |
| 03/28/2007 | CN1935256A Technology for preparing compound human inter feron spray agent capable of preventing polytypic influenza |
| 03/28/2007 | CN1935255A Slow-release gamma-interferon nano capsule, and its preparing method and use |
| 03/28/2007 | CN1935254A Neuregulin for treating cardio vascular disease, and its method and composition |
| 03/28/2007 | CN1935253A Cerebral proteolysis dispersible tablet and its preparing method |
| 03/28/2007 | CN1307303C Methods and compositions based on VEGF antisense oligonucleotides |
| 03/28/2007 | CN1307200C Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use |
| 03/28/2007 | CN1307199C Bone pattern generation protein 2 active peptide and its preparation method and application |
| 03/28/2007 | CN1307197C Heterosides peptide injection liquor for improving animal immunological function |
| 03/28/2007 | CN1306964C Decoy composition for treating and preventing inflammatory disease |
| 03/28/2007 | CN1306963C Remedy for diseases caused by IL-6 production |
| 03/28/2007 | CN1306955C Sodium ferulic acid albumin nano granular preparation and its preparing method |
| 03/28/2007 | CN1306954C Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
| 03/27/2007 | US7196188 Methods and compositions for screening of human borna disease virus |
| 03/27/2007 | US7196184 Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene |
| 03/27/2007 | US7196181 made in non-thyroidal eukaryotic cells; for diagnosis and treatment of immune disorders such as Hashimoto's thyroiditis |
| 03/27/2007 | US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/27/2007 | US7196171 Alstrom syndrome is a homogeneous autosomal recessive disorder characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia, and neurosensory deficiency; isolated polypeptide |
| 03/27/2007 | US7196170 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 03/27/2007 | US7196164 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/27/2007 | US7196163 Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| 03/27/2007 | US7196162 Anti-aging and wound healing compounds |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196070 Contacting, by ductal cannulation, the ductal epithelium of the exocrine gland with a cytolytic virus to destroy less than all of the ductal epithelium so as to inhibit formation of cancer of ductal epithelial origin |
| 03/27/2007 | US7196068 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 03/27/2007 | US7196067 Which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells; gene expression inhibition |
| 03/27/2007 | US7196065 Enteral formulation |
| 03/27/2007 | US7196063 Peptides and pharmaceutical compositions comprising same |
| 03/27/2007 | US7196062 Caldesmon, a protein found in smooth muscle and non-muscle cells, causes secondary degeneration of the actin-microfilament network and thereby interferes with actomyosin contractility and with formation of focal cell adhesions; reducing eye pressure |
| 03/27/2007 | US7196061 cyclic peptides and peptidomimetic used as agonists or antagonists of tyrosine kinase receptors; modulation of growth and repair of the central nervous system |
| 03/27/2007 | US7196060 Method to enhance hematopoiesis |
| 03/27/2007 | US7196059 Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith |